Sundrug Co.,Ltd.
SDGCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $801,811,000 | $751,777,000 | $690,462,000 | $648,734,000 |
| % Growth | 6.7% | 8.9% | 6.4% | – |
| Cost of Goods Sold | $597,723,000 | $562,457,000 | $3,902,870 | $4,043,653 |
| Gross Profit | $204,087,000 | $189,320,000 | $1,294,238 | $1,285,697 |
| % Margin | 25.5% | 25.2% | 0.2% | 0.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $10,000 | $0 | $0 | $0 |
| SG&A Expenses | $142,305,000 | -$5,000 | $1,012,344 | $1,005,960 |
| Sales & Mktg Exp. | $142,295,000 | $0 | $0 | $0 |
| Other Operating Expenses | $17,287,000 | $148,324,000 | $0 | $0 |
| Operating Expenses | $159,592,000 | $148,319,000 | $1,012,344 | $1,005,960 |
| Operating Income | $44,496,000 | $40,996,000 | $37,452,000 | $34,052,000 |
| % Margin | 5.5% | 5.5% | 5.4% | 5.2% |
| Other Income/Exp. Net | -$927,000 | $265,000 | $258,000 | $623,000 |
| Pre-Tax Income | $43,569,000 | $41,261,000 | $37,710,000 | $34,675,000 |
| Tax Expense | $12,818,000 | $12,134,000 | $12,007,000 | $10,821,000 |
| Net Income | $30,750,000 | $29,126,000 | $25,703,000 | $23,853,000 |
| % Margin | 3.8% | 3.9% | 3.7% | 3.7% |
| EPS | 262.91 | 249.07 | 219.83 | 204.02 |
| % Growth | 5.6% | 13.3% | 7.7% | – |
| EPS Diluted | 262.91 | 249.07 | 219.82 | 204.01 |
| Weighted Avg Shares Out | 116,963 | 116,939 | 116,923 | 116,918 |
| Weighted Avg Shares Out Dil | 116,963 | 116,939 | 116,931 | 116,923 |
| Supplemental Information | – | – | – | – |
| Interest Income | $151,000 | $120,000 | $119,000 | $122,000 |
| Interest Expense | $164,000 | $32,000 | $36,000 | $9,000 |
| Depreciation & Amortization | $17,282,000 | $15,127,000 | $12,068,000 | $10,209,000 |
| EBITDA | $61,015,000 | $56,124,000 | $49,814,000 | $44,893,000 |
| % Margin | 7.6% | 7.5% | 7.2% | 6.9% |